Acute Renal Failure in Different Malignant Tumors

Author(s): Sanja Radojevic-Skodric, Ljiljana Bogdanovic, Milena Jovanovic, Ivana Baralic, Zoran Dzamic, Ron Gordon, Simona Ognjanovic, Gordana Basta-Jovanovic

Journal Name: Current Medicinal Chemistry

Volume 23 , Issue 19 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Acute renal failure (ARF) represents a severe complication of malignancies, that causes significant morbidity and mortality. ARF is a common part of multiple organ dysfunction in critically ill patients with cancer with reported mortality rates from 72% to 85% in patients who need renal replacement therapy. The pathways leading to ARF in cancer patients are common to the development of ARF in other conditions. However, certain factors leading to the development of ARF may be associated to the tumor or to the tumor therapy. The purpose of this review is to give specific aspects of renal disease in critically ill cancer patients (CICPs), to overview the causes of ARF in CICPs and to describe recent progress in the management of these complications, including treatment toxicity and bone marrow transplantation (BMT). The prevention of ARF is obligatory and therefore the possible treatments of ARF in CICPs are also discussed.

Keywords: Acute renal failure, tumor lysis syndrome, hepatocellular carcinoma (HCC), multiple myeloma, lymphoma.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 18 July, 2016
Page: [2041 - 2046]
Pages: 6
DOI: 10.2174/0929867323666160407113245
Price: $65

Article Metrics

PDF: 32